Concomitant use of valproic acid (VPA) and meropenem (MEPM) is associated with a decrease in VPA plasma levels, according to a study published online in the Journal of Clinical Pharmacy and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback